Last year 23andMe and Genentech launched an online study of metastatic breast cancer to learn more about what role genes might play in how a person responds to bevacizumab, also...

In any big fight it helps to have someone in your corner and when it comes to breast cancer you want someone like Elyse Spatz Caplan and the people at...

Not all cancers are created equal. Ask anyone with metastatic breast cancer. For the 155,000 women in the United States living with this diagnosis, each day represents a constant fight...

Earlier this year 23andMe and Genentech launched an online study of metastatic breast cancer to learn more about how genes might play a role in how a person responds to...

23andMe is passionate about fighting cancer. We recently launched a Cancer Family History survey and within two months more than 20,000 customers have answered! We're already learning some very interesting things -- read on.

Cancer is not one disease, but many, and this has been one of the most challenging aspects of researching cures for cancer. 23andMe is applying its unique research platform to study cancer with research communities focused on sarcoma, myeloproliferative neoplasms, and metastatic breast cancer. Patients from all over the world can contribute directly to research and connect with others who have their disease, all while learning more about themselves.

A few of us from 23andMe attended the 6th Annual Conference for Women Living with Metastatic Breast Cancer two weekends ago in Philadelphia. This national conference is put on by...

Clinical trials are often conducted at major hospitals and medical centers.    As you can imagine, it can be expensive to use hospital resources and take a large amount of...